Stephens initiated coverage on shares of Treace Medical Concepts (NASDAQ:TMCI – Get Rating) in a research note released on Monday morning, Marketbeat.com reports. The brokerage issued an equal weight rating and a $26.00 target price on the stock. Separately, Morgan Stanley increased their price target on shares of Treace Medical Concepts from $28.00 to $30.00 […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director Richard W. Mott sold 4,043 shares of Treace Medical Concepts stock in a transaction dated Thursday, April 6th. The shares were sold at an average price of $26.00, for a total value of $105,118.00. Following the completion of the transaction, the director now owns 905,000 shares […]
Equities research analysts at Stephens started coverage on shares of Treace Medical Concepts (NASDAQ:TMCI – Get Rating) in a note issued to investors on Monday, The Fly reports. The brokerage set an “equal weight” rating on the stock. Separately, Morgan Stanley upped their price objective on shares of Treace Medical Concepts from $28.00 to $30.00 […]
Allspring Global Investments Holdings LLC increased its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) by 278.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 478,815 shares of the company’s stock after buying an additional 352,208 shares during the period. Allspring Global […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director Richard W. Mott sold 38,498 shares of Treace Medical Concepts stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $26.00, for a total transaction of $1,000,948.00. Following the completion of the sale, the director now owns 1,020,000 shares […]